Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-067018

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 8:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 17, 2015M44,871$0.00A107,527D
Common StockF1Aug 17, 2015M9,291$0.00A116,818D
Common StockF1Aug 17, 2015M4,359$0.00A121,177D
Common StockF3Aug 18, 2015S5,764$49.38D115,413D
Common StockF4Aug 19, 2015S4,375$47.98D111,038D
Common StockF5Aug 19, 2015S1,500$48.78D109,538D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF6,F7,F8—Aug 17, 2015M44,871D——Common Stock44,8710D
Restricted Stock UnitsF6,F9,F10—Aug 17, 2015M9,291D——Common Stock9,29115,485D
Restricted Stock UnitsF6,F11,F12—Aug 17, 2015M4,359D——Common Stock4,3598,717D

Explanation of responses